SBIR-STTR Award

The overall goal of this application is to develop an understanding of the collection, processing and cryobiological characteristics of stem/progenitor cells recovered from extracted teeth with the ultimate culmination of these data to allow for a cryobank of Dental pulp derived stem cells (DPSCs) for research and/or potential transplant or other clinical utilization as a human cell product processed under current good tissue practice (cGTP) as described under 21 CFR 1271. Recent studies investigating this exciting source of post-natal stem cells have identified a population of clonogenic and highly proliferative cells derived from enzymatically digested Dental pulp tissue (Gronthos, et al., 2000). Results from these studies have indicated that these cells may have the potential to be utilized in stem cell mediated therapies and tissue engineering applications (Seo, et al., 2005). To allow further study and potential therapeutic use of these cells, investigators have just begun to evaluate the ability of these cells and their respective tissues of origin to survive cryopreservation processing. Ideally, the optimum cryopreservation process will be straight forward and effective when applied to the tissue as a whole, with the idea that stem cells could be extracted post-thaw. The rationale for this would be to preserve clinical samples for subsequent stem cell recovery as it is reasonable to speculate that cryopreservation of tissues in the clinic will be more practical than direct primary isolation of stem cells, which would require additional equipment and personnel (Seo et al., 2005). A cryobank of these cells would add great flexibility to their use by allowing, among other things, shipment of cells to investigators and/or clinicians and adequate time for donor characterization and/or potential testing. To achieve this overall goal, we propose to begin with the following Specific Aims: (I) Optimization of collection, transportation and processing of extracted teeth; (II) Optimization of cryopreservation of tooth derived stem cells; and (III) Final development of optimized, cGTP protocols for development of a tooth stem cell bank for distribution and use. Ultimate feasibility of developing a cryobank of DPSCs will be considered achieved if e90% functional recovery of these cells is retained using the most sensitive assay available when compared to their unfrozen counterparts. Public Health Significance: Stem cells can develop into different tissues types in the body. Post-natal, or adult stem cells offer an alternative to obtaining stem cells from embryos. Such stem cells exist in human teeth, but more research is required before these cells can have direct clinical use. A bank of frozen stem cells from teeth would be ideal to facilitate this research. This proposed project would optimize methods for processing and freezing these cells for ease of distribution for research, testing, and eventually clinical use.

Public Health Relevance:
This Public Health Relevance is not available.

Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.

The overall goal of this proposal is to build on our understanding of the collection, processing and cryobiological characteristics of stem/progenitor cells recovered from extracted teeth with the ultimate culmination of these data to develop a cryobank of dental pulp derived stem cells (DPSCs) for research and/or potential transplant or other clinical utilization as a human cell product processed under current good tissue practice (cGTP) as described under 21 CFR 1271. Recent studies investigating this exciting source of post-natal stem cells have identified a population of clonogenic and highly proliferative cells derived from enzymatically digested dental pulp tissue (Gronthos et al., 2000; Perry et al., 2008). Results from these studies have indicated that these cells may have the potential to be utilized in stem cell mediated therapies as well as tissue engineering applications (Seo et al., 2005). To allow further study and potential therapeutic use of these cells, our group has begun to evaluate the ability of these cells and their respective tissues of origin to survive cryopreservation processing. Ideally, the optimum cryopreservation process will be straight forward and effective when applied to the tissue as a whole, with the idea that stem cells could be extracted post-thaw. The rationale for this would be to preserve clinical samples for subsequent stem cell recovery as it is reasonable to speculate that cryopreservation of tissues in the clinic will be more practical than direct primary isolation of stem cells, which would require additional equipment and personnel (Seo et al., 2005; Perry et al., 2008). A cryobank of these cells would add great flexibility to their use by allowing, among other things, shipment of cells to investigators and/or clinicians and adequate time for donor characterization and/or potential testing. To achieve this overall goal, we propose the following Specific Aims: (I) Final development of optimized, cGTP protocols for development of a tooth stem cell bank for distribution and use; (II) Final development cGTP protocols for cryobanking of tooth tissue for later stem/progenitor cell isolation and expansion; and (III) Development and validation of a closed container for packaging and distribution of cells for clinical use. The ultimate goal of the proposal is a cryobank of DPSCs or tissue with e90% consistent functional recovery of cells based on the most sensitive assays available when compared to their unfrozen counterparts. For Specific Aim III the goal will be an FDA approved packaging system useful for clinical utilization of stem/progenitor cells derived from teeth. This system will also be useful for other clinically relevant stem cell sources where smaller volumes are required.

Public Health Relevance:
Stem cells can develop into different tissues types in the body. ""Post-natal"" or ""adult"" stem cells offer an alternative to obtaining stem cells from embryos. Such stem cells exist in human teeth, but more research is required before these cells can have direct clinical use. A bank of frozen stem cells from teeth would be ideal to facilitate this research. This proposed project would optimize methods for processing and freezing these cells for ease of distribution for research, testing, and eventually clinical use, as well as present the ability for one to store tissue from their own teeth for potential use of their own cells if/when needed.

Thesaurus Terms:
Assay; Autologous; Bioassay; Biologic Assays; Biological Assay; Body Tissues; Bone; Bone And Bones; Bones And Bone Tissue; Cartilage; Cartilagenous Tissue; Cell Isolation; Cell Segregation; Cell Separation; Cell Separation Technology; Cells; Characteristics; Clinic; Clinical; Clinical Trials, Phase Ii; Collection; Crossmatching, Tissue; Cryofixation; Cryopreservation; Data; Degenerative Disorder; Dental Pulp; Development; Embryo; Embryonic; Ensure; Equipment; Fda Approved; Freezing; Future; Goals; Histocompatibility Testing; Human; Human Resources; Human, General; Individual; Investigators; Laboratory Manuals (Pt); Laboratory Manuals [publication Type]; Man (Taxonomy); Man, Modern; Manpower; Mediating; Methods; Mother Cells; Phase 2 Clinical Trials; Phase Ii Clinical Trials; Population; Preparation; Procedures; Process; Production; Progenitor Cells; Protocol; Protocols Documentation; Recovery; Recovery Of Function; Research; Research Personnel; Researchers; Sampling; Source; Stem Cell Research; Stem Cells; System; System, Loinc Axis 4; Testing; Therapeutic Uses; Time; Tissue Crossmatchings; Tissue Engineering; Tissue Typing; Tissues; Tooth; Tooth Tissue; Tooth Structure; Transplantation; Validation; Adult Stem Cell; Base; Bone; Cell Bank; Cell Sorting; Clinical Relevance; Clinically Relevant; Cold Preservation; Cold Storage; Degenerative Condition; Degenerative Disease; Engineered Tissue; Flexibility; Functional Recovery; Histocompatibility Typing; Laboratory Manuals; New Approaches; Novel Approaches; Novel Strategies; Novel Strategy; Personnel; Phase 2 Study; Phase 2 Trial; Phase Ii Trial; Protocol Development; Protocol, Phase Ii; Public Health Relevance; Pulp; Stem; Study, Phase Ii; Teeth; Transplant